Year: 2025

PwC serves as the certifying entity for HEIMAR250948 and the general security arrangement. Its role includes, among other things, reviewing and confirming the issuer’s calculations in the report on financial covenants. PwC has now conducted a review of the issuer’s calculations regarding the financial covenants of the bond series HEIMAR250948 and the general security arrangement. The conclusion of PwC’s review confirms that the bond series HEIMAR250948 and the general security arrangement comply with all financial covenants as of 31.12.2024. Further findings from the review are included in the attached documents, which are in Icelandic.AttachmentsPwC staðfesting 31.12.2024 Almenna – skýrsla um fjárhagslegar kvaðir – 110325PwC staðfesting 31.12.2024 Sértæka – skýrsla um fjárhagslegar...

PHOENIX, March 12, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its indirect subsidiary Williams Scotsman, Inc. (“WSI”), will solicit consents (“Consents”) from the holders of its existing 6.625% Senior Secured Notes due 2029 (the “2029 Notes”) and the holders of its 7.375% Senior Secured Notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Existing Notes”) as of the record date of March 11, 2025 (the “Record Date”) to amend (the “Proposed Amendments”) certain provisions of the indentures governing the Existing Notes. The consent solicitations for each series of Existing Notes (collectively, the “Consent Solicitations” and, with respect to each series, a “Consent Solicitation”) are being...

LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) — Big Screen Entertainment Group (OTC: BSEG) is making a bold expansion into the booming beauty industry—an ever-growing global market projected to exceed $700 billion by 2028. The Los Angeles-based film and television company has completed filming on the pilot episode of a beauty-focused TV show, seamlessly integrating a new line of cutting-edge beauty products backed by top industry experts. This venture marks a strategic expansion for Big Screen, leveraging its entertainment expertise to enter one of the most profitable consumer sectors. While the name of the series and details of the product line remain confidential for now, audiences can expect a blend of Hollywood glamour and transformative beauty experiences featuring a lineup of well-known faces. Among them is celebrated actress Kelli...

ATHENS, Greece, March 12, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International SA, Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Medusa. The gross charter rate is US$13,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum May 15, 2026 up to maximum July 15, 2026. The charter is expected to commence on March 15, 2025. The “Medusa” is an 82,194 dwt Kamsarmax dry bulk vessel built in 2010. The employment of “Medusa” is anticipated to generate approximately US$5.46 million of gross revenue for the minimum scheduled period of the time...

GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the pricing of an underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (the “Offering”). The aggregate gross proceeds to Shuttle Pharma from the Offering are expected to be approximately $5.75 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Shuttle Pharma. The Offering is expected to close on March 13, 2025, subject to the satisfaction of customary...

PITTSBURGH, March 12, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), the leader in advanced laser technology, is proud to announce the launch of its groundbreaking 793nm pump laser diode, setting a new industry standard with an impressive 28W of reliable power and 97% polarization purity. This innovative product offers unmatched performance and cost-efficiency, unlocking new possibilities for applications in the rapidly growing Thulium fiber laser market. A Game-Changer in Thulium Fiber Laser TechnologyThe increasing adoption of Thulium fiber lasers in medical applications has transformed patient care, offering a safer, more comfortable treatment experience with faster recovery times. With the market for Thulium fiber lasers projected to grow significantly, the new 793nm chip from Coherent is poised to meet the growing demand...

Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b clinical trial. Portage had previously paused this trial due to funding concerns; this resumption of the trial underscores the encouraging findings observed in earlier cohorts. After the completion of the PORT-6 arm of the ADPORT-601 study, Portage will evaluate the continuation of the study into its PORT-7 (potent and...